The consumer-genomics company 23andMe just sold its biobank of customer genetic data to drugmaker Regeneron for $256 million.

Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.

  • primalmotion@lemmy.ml
    2·
    1 day ago

    Ah. You think Discord, that is not an free software product, controlled by one corpo, is immune to enshitification. When will people learn?

    • bblkargonaut@lemmy.world
      1·
      1 day ago

      Definitely not, enshitification is real. I’ve gone from someone excited about new products to I don’t trust anything that I didn’t build. We are currently discussing moving our group chat off discord, but I’m biochemist and my circle are similar professions and I’m still learning how to properly host things.